Piedmont Columbus (Ga.) Regional Midtown is one of the first U.S. hospitals to administer Tzield, a newly approved therapy that delays the progression of Type 1 diabetes by two to seven years.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
